FDA warns of birth defects with Topamax

(AP) -- The Food and Drug Administration is warning women of child-bearing age that the epilepsy drug Topamax can increase the risk of birth defects around the mouth.

Data collected from a registry of pregnant women showed a higher rate of cleft lip and cleft palate in babies whose mothers were taking the drug during the first trimester.

Topamax is marketed by Johnson & Johnson to control seizures caused by , a neurological disorder that causes excessive signals in the brain. The drug is also used to relieve migraine headaches.

J&J and generic drugmakers who market the drug, known as topiramate, will add a stronger warning label about the drug's effect on pregnancies.

Women taking topiramate should talk to their doctor immediately if they are planning to or become pregnant.


Explore further

Epilepsy drug may increase risk of birth defects

©2010 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Citation: FDA warns of birth defects with Topamax (2011, March 4) retrieved 5 July 2020 from https://medicalxpress.com/news/2011-03-fda-birth-defects-topamax.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments